Related Articles by Review for PMID: 32310508

Year	Number of Results
2015	1
2017	2
2018	1
2019	8
2020	12
2021	8
2022	9
2023	8
2024	8
2025	1

1

Meissner H, Cascella M. Meissner H, et al. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32310508 Free Books & Documents.

2

Cannabis for the Treatment of Epilepsy: an Update.

Gaston TE, Szaflarski JP. Gaston TE, et al. Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Curr Neurol Neurosci Rep. 2018. PMID: 30194563 Review.

3

The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials.

Aderinto N, Olatunji G, Kokori E, Ajayi YI, Akinmoju O, Ayedun AS, Ayoola OI, Aderinto NO. Aderinto N, et al. Eur J Med Res. 2024 Mar 18;29(1):182. doi: 10.1186/s40001-024-01788-6. Eur J Med Res. 2024. PMID: 38500226 Free PMC article. Review.

4

Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.

Golub V, Reddy DS. Golub V, et al. Adv Exp Med Biol. 2021;1264:93-110. doi: 10.1007/978-3-030-57369-0_7. Adv Exp Med Biol. 2021. PMID: 33332006 Review.

5

Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.

Balachandran P, Elsohly M, Hill KP. Balachandran P, et al. J Gen Intern Med. 2021 Jul;36(7):2074-2084. doi: 10.1007/s11606-020-06504-8. Epub 2021 Jan 29. J Gen Intern Med. 2021. PMID: 33515191 Free PMC article. Review.

6

Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.

Del Pozo A, Barker-Haliski M. Del Pozo A, et al. Exp Neurol. 2023 Feb;360:114288. doi: 10.1016/j.expneurol.2022.114288. Epub 2022 Nov 26. Exp Neurol. 2023. PMID: 36471511 Free PMC article. Review.

7

A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development.

Samanta D. Samanta D. Epilepsy Behav. 2022 Mar;128:108577. doi: 10.1016/j.yebeh.2022.108577. Epub 2022 Feb 9. Epilepsy Behav. 2022. PMID: 35151190

8

Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes.

Chen JW, Borgelt LM, Blackmer AB. Chen JW, et al. Ann Pharmacother. 2019 Jun;53(6):603-611. doi: 10.1177/1060028018822124. Epub 2019 Jan 8. Ann Pharmacother. 2019. PMID: 30616356 Review.

9

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.

Mlost J, Bryk M, Starowicz K. Mlost J, et al. Int J Mol Sci. 2020 Nov 23;21(22):8870. doi: 10.3390/ijms21228870. Int J Mol Sci. 2020. PMID: 33238607 Free PMC article. Review.

10

Cannabidiol Adverse Effects and Toxicity.

Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 32310508

54 results

Results by year